Saudi Arabia Anti-Snoring Devices Market Overview, 2031

The market for anti-snoring devices in Saudi Arabia has seen consistent growth within the GCC, becoming one of the most sophisticated markets in the area and increasingly in sync with trends in sleep health. These devices aim to tackle both primary snoring and obstructive sleep apnea OSA, conditions that are now acknowledged in Saudi Arabia as factors contributing to heart disease, obesity, and decreased productivity. Awareness began to rise in the late 2000s, mainly through sleep clinics in Riyadh and Jeddah, and later spread to private healthcare systems and retail stores. Common users are middle-aged individuals, older people, and younger workers who suffer from positional snoring related to their lifestyles. On a technical level, CPAP devices provide a steady stream of air to prevent the airway from collapsing, while mandibular advancement devices MADs shift the jaw position to decrease blockage. Nasal dilators enhance airflow mechanically, and EPAP devices help maintain breathing by offering resistance during exhalation. These methods lead to significant benefits, including improved sleep quality, less daytime tiredness, and better job performance. Saudi Arabia has poured resources into research and development by fostering partnerships between universities, medical centers, and device manufacturers, concentrating on user-friendly oral devices and advanced CPAP systems equipped with connectivity options. Regulatory systems managed by the Saudi Food and Drug Authority SFDA ensure these products are safe and meet standards, which boosts consumer confidence and complies with international benchmarks.

According to the research report, "Saudi Arabia Anti-Snoring Overview, 2031," published by Bonafide Research, the Saudi Arabia Anti-Snoring market is anticipated to add to more than 22.13 Million by 2026–31. The landscape of anti-snoring products in Saudi Arabia is evolving, influenced by changing consumer awareness about health issues associated with sleep disorders. Factors such as stress, obesity, and the hustle of urban life contribute to the rise of snoring and related conditions among the population. As more individuals recognize the significance of quality sleep, there is growing acceptance of various anti-snoring solutions. This shift is partly driven by the availability of more advanced technologies and devices designed for comfort and efficiency. Marketing strategies targeting both healthcare professionals and consumers are also becoming more prevalent, with educational campaigns highlighting the potential health impacts of snoring. , growing access to e-commerce platforms has made it easier for consumers to explore different product options and make informed purchases. The integration of modern features, such as sleep tracking and mobile app connectivity, has enhanced the appeal of these devices. The diverse range of available products, including mouthpieces, nasal sprays, and specialized pillows, caters to varied preferences and needs. As the market continues to adapt to consumer demands and technological advancements, companies are likely to invest more in innovative solutions that suit a wider audience. The anti-snoring devices sector in Saudi Arabia is on a trajectory of promising growth, supported by a collaborative effort between healthcare providers, consumers, and manufacturers to improve the quality of sleep and well-being.

Saudi Arabia anti snoring devices by product is divided into mandibular advancement devices MADs, tongue stabilizing devices TSDs, continuous positive airway pressure CPAP devices, nasal devices, positional therapy devices, expiratory positive airway pressure EPAP devices and others. In Saudi Arabia, the market for devices addressing anti-snoring and sleep apnea is steadily expanding, influenced by growing awareness of sleep-related issues and higher obesity levels. The range of devices available includes mandibular advancement devices MADs, tongue-stabilizing devices TSDs, continuous positive airway pressure CPAP machines, nasal devices, positional therapy options, expiratory positive airway pressure EPAP devices, among other aids. CPAP machines are the leading choice for treating moderate to severe obstructive sleep apnea OSA due to their proven effectiveness, whereas MADs and TSDs are being increasingly utilized for mild OSA or for those who find CPAP difficult to tolerate. Nasal aids, like strips and dilators, are commonly employed for basic snoring and minor airway blockage, providing a cost-effective and non-invasive alternative. Positional therapy tools, which include specialized pillows and wearable straps, are gaining traction as al treatments to minimize snoring when lying on the back. EPAP devices, which are compact and user-friendly, are becoming a favorable substitute for patients in search of non-invasive therapy options. The Saudi market is supported by robust hospital networks, an increase in private health care investments, and strong consumer buying power that benefits both advanced clinical devices and moderately priced oral appliances. The supply is largely composed of imports from Europe, the United States, and Asia, with local production being relatively low.

Saudi Arabia anti snoring devices by type of snoring/indication is divided into primary snoring Simple Snoring and obstructive sleep apnea OSA-related snoring. The Saudi market is primarily influenced by snoring related to OSA, though primary snoring remains a significant issue, especially among younger and middle-aged individuals. Factors related to lifestyle, such as a high rate of obesity, lack of physical activity, and certain dietary habits, are major contributors to the occurrence of OSA. CPAP machines are the standard treatment for those clinically diagnosed with moderate to severe OSA, while MADs and TSDs are favored for mild OSA or for individuals who cannot tolerate CPAP treatment. Nasal devices and positional aids cater to patients experiencing primary snoring or minor obstruction, providing affordable, non-invasive choices that do not necessitate professional medical supervision. Growing awareness of cardiovascular and metabolic risks tied to untreated OSA has led both patients and medical professionals to focus more on diagnosis and treatment. The availability of sleep studies and diagnostic services in Saudi Arabia is on the rise, especially in major cities like Riyadh, Jeddah, and Dammam, allowing for targeted interventions based on the type and seriousness of snoring. , government health programs and insurance options are improving access to medically prescribed devices. Altogether, the market illustrates a division by indication, where clinical-level treatments address OSA, while consumer-level, lower-intensity devices manage primary snoring, balancing medical supervision with solutions for self-care.

Saudi Arabia anti snoring devices by distribution channel is divided into E-commerce/Online Platforms and other hypermarkets/supermarkets, specialty stores. Distribution channels in Saudi Arabia include a mix of institutional, retail, and new digital options. The main sources for CPAP devices, custom MADs, and medically supervised treatments are hospitals and sleep clinics, where they provide diagnostic evaluations, fitting of devices, and ongoing support. Retail pharmacies and drugstores offer easy access to over-the-counter nasal devices, EPAP, and positional aids, catering to patients who experience simple snoring or mild sleep-related breathing issues. Online shopping sites are becoming more popular, especially for MADs, supplemental items, and portable EPAP devices, showing that consumers are increasingly comfortable buying online. Specialty shops and large supermarkets play a smaller part, concentrating on product visibility and low-intensity options. The market is monitored to ensure the safety and effectiveness of devices, particularly for those requiring prescriptions like CPAP. The distribution framework in Saudi Arabia highlights the importance of medical oversight for serious cases while also allowing consumer-friendly access to non-prescription devices, creating a balanced environment that supports both medical compliance and convenient purchasing options.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Anti-snoring Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By product
• Mandibular Advancement Devices (MADs)
• Tongue Stabilizing Devices (TSDs)
• Continuous Positive Airway Pressure (CPAP) Devices
• Nasal Devices
• Positional Therapy Devices
• Expiratory Positive Airway Pressure (EPAP) Devices
• Others

By Type of Snoring/Indication
• Primary Snoring (Simple Snoring)
• Obstructive Sleep Apnea (OSA)-Related Snoring

By Distribution Channel
• Retail Pharmacies & Drug Stores
• Hospital & Sleep Clinics
• E-commerce/Online Platforms (A rapidly growing segment due to DTC brands)
• Other (Hypermarkets/Supermarkets, Specialty Stores)